Rekrutierung

Eingeschlossene Patienten: 22.798 (Stand 03. Juni 2024)
Amgevita® (Adalimumab)220
Benepali® (Etanercept)1193
Cimzia® (Certolizumab)1027
Enbrel® (Etanercept)2872
Erelzi® (Etanercept)528
Flixabi® (Infliximab)10
Hukyndra® (Adalimumab)2
Hulio® (Adalimumab)244
Humira® (Adalimumab)2909
Hyrimoz® (Adalimumab)216
Idacio® (Adalimumab)62
Imraldi® (Adalimumab)216
Inflectra™ (Infliximab)17
Jyseleca® (Filgotinib)138
Kevzara® (Sarilumab)218
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Nepexto® (Etanercept)75
Olumiant® (Baricitinib)537
Orencia® (Abatacept)975
Remicade® (Infliximab)762
Remsima® (Infliximab)21
Rinvoq® (Upadacitinib)303
Rixathon® (Rituximab)20
RoActemra® (Tocilizumab)1374
Ruxience® (Rituximab)1
Simponi® (Golimumab)467
Truxima® (Rituximab)2
Tyenne® (Tocilizumab)6
Xeljanz® (Tofacitinib)396
Yuflyma® (Adalimumab)26
Zessly® (Infliximab)2
Kontrollen6411